Morgan Stanley Maintains Overweight on Rollins, Lowers Price Target to $65

Benzinga Newsdesk www.benzinga.com Negative 78.5%

Neg 78.5% Neu 0% Pos 0%

Morgan Stanley analyst Toni Kaplan maintains Rollins (NYSE:ROL) with a Overweight and lowers the price target from $70 to $65.